Black futures fell rapidly in the short term, with the main contracts of hot coil and coking coal falling by more than 1%, and the main contracts of coke, thread and iron ore falling by nearly 1%.Leshan Guotou Group and others set up an industrial guidance equity investment fund with a capital contribution of 4.5 billion yuan. According to Tianyancha App, recently, Leshan Jiarong Industrial Guidance Equity Investment Fund Partnership (Limited Partnership) was established, and the executive partner is Leshan Guorong Equity Investment Fund Management Co., Ltd., with a capital contribution of 4.5 billion yuan, and its business scope includes investment activities with its own funds. According to the partner information, the fund is jointly funded by Leshan State-owned Assets Investment and Operation (Group) Co., Ltd., Leshan Finance Bureau and Leshan Guorong Equity Investment Fund Management Co., Ltd.Guoxuan Hi-Tech: It plans to invest a total of 2.514 billion euros to build new energy battery production bases in Slovakia and Morocco. Guoxuan Hi-Tech announced that the company plans to invest in Slovakia with its own and self-raised funds to build high-performance lithium batteries and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.234 billion euros. On the same day, it was announced that the company plans to invest in Morocco with its own and self-raised funds to build a high-performance lithium battery and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.28 billion euros.
Tianyu Bio staged the "Heaven and Earth" market in the afternoon, with a turnover of over 900 million yuan.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)The legal representative of Sanzhiyang Culture Media Co., Ltd. changed. Tianyancha App showed that on December 10, Hefei Sanzhiyang Culture Media Co., Ltd. changed its business. Ba Shuai stepped down as the legal representative, executive director and general manager, and Zhang Yong was the legal representative, director and manager. The company was established in May 2022 with a registered capital of RMB 1 million. Its business scope includes radio and television program production and operation, performance brokerage, advertising, organization of cultural and artistic exchange activities, conference and exhibition services, etc. It is wholly owned by Hefei Sanzhiyang Network Technology Co., Ltd.
The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Bank of America Securities lowered the Adobe target price from $640.00 to $605.00.In the direction of pan-consumption, there were more than 50 stocks with daily limit, and the concept of big consumption continued to strengthen. Retail, food, home, ice and snow industries and other branches set off a wave of daily limit, and Zhongbai Group, Youhao Group, Huifa Food, Panda Dairy, Wole Home and Meike Home exceeded 50 stocks with daily limit.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13